prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumB, F. Pathologic Interpretation: A. Lymph node, sentinel lymph node: - No malignancy seen in one lymph node (0/1). - Keratin immunostain pending. B. Skin left breast: - Skin, no pathologic change. C. Left breast lumpectomy: - Infiltrating poorly differentiated ductal carcinoma, high nuclear grade, 2.4 cm in greatest dimension. - Margins of resection are free of tumor. - Lymphovascular space invasion is present. - Previous biopsy site identified. - The tumor cells are positive for ER and PR, and negative for Her2. - See tumor summary. D. Inferior margin, true blue margin: - No malignancy seen. E. Right breast tissue: - Fibrocystic changes with stromal fibrosis, adenosis, and microcalcifications. - Previous biopsy site identified. Tumor Summary: Specimen Type: Excision. Lymph Node Sampling: Sentinel lymph node(s) only. Specimen Size: Greatest dimension: 7.5 cm. Additional dimensions: 5.5 x 4.0 cm. Laterality: Left. Tumor Site: Not specified. Size of Invasive Component: Greatest dimension: 2.4 cm. Additional dimensions: 1.5 x 1.0 cm. Histologic Type: Invasive ductal carcinoma. Histologic Grade: Tubule Formation: Minimal less than 10% (score =3). Nuclear Pleomorphism: Marked variation in size, nucleoli, chromatin clumping, etc (score =3). Mitotic Count: Greater than 20 mitoses per 10 HPF (score =3). Total Nottingham Score: Grade III: 8-9 points. Pathologic Staging (pTNM). Primary Tumor: pT2. Regional Lymph Nodes: pNO. Number examined: 1. Number involved: o. Distant Metastasis: pMX. Margins: Uninvolved by invasive carcinoma. Venous/Lymphatic Invasion: Present. Microcalcifications: Present in both tumor and non-neoplastic tissue. Comments: ER: Positive. PR: Positive (. Her2: Negative (. SURGICAL PATHOL Report. that. do. NOTE: Some immunohistochemice/ These clones antibodies are used: are ID5=ER, analyte specific Por 636=PR, reagents A485=HER2, (ASRs) validated H-11=EGFR, by our laboratory CCH2/DOG9=CMV, (Her 2, Parvo, F39.4.1=AR H pylon, or negative. and HBcore) HPV by These ISH ASRs All immunohistochemca/ are clinically useful indicators stains are used. not with require formakin FDA or molecular approval. fixed, parafin embedded tissue Detection is by LSAB. The results are read by 8 pathologist as positive. - MD. As the attending pathologist, / attest that I: (i) Examined the relevant. preperation(s) for the specimen(s); and (ii) Rendered the diegnosis(es). Procedures/Addenda. Addendum. Date Complete: Addendum Diagnosis. Keratin immunostain is negative for carcinoma. , MD. Intraoperative Consultation. AFS. Sentinel lymph node #1: Touch prep only: Lymphoid cells. No malignant cell seen. CFS. Left breast lumpectomy: Portion from mass (1 x 0.5 x 0.3cm) taken for tissue bank. Clinical History: Patient is a. female with history of breast cancer. Pre Operative Diagnosis: Left breast cancer. Specimen(s) Received: A: Lymph node, sentinel lymph node. B: Skin left breast. C: Left breast lumpectomy. D: Inferior margin, true blue margin. E: Right breast tissue (fresh). Gross Description: A. Received fresh and labeled "lymph node, sentinel lymph node" consists of a lymph node, 1.0 x 0.8 x 0.7 cm. Specimen is. multisected and submitted in toto in one cassette for touch prep. ". B. Received in formalin and labeled "skin left breast" consists of a ellipse of skin, 5.0 cm in length by 1.7 x 0.4 cm. Representative section submitted in one cassette. C. Received fresh and labeled "left breast lumpectomy 1short superior 1 long lateral" consists of a lumpectomy which weighs. 90.0 grams after formalin fixation and measure 7.5 cm from medial to lateral, 5.5 cm from anterior to posterior and 4.0 cm. from superior to inferior. Specimen inked as follows. Superior and inferior margin inked black, medial and lateral margins. inked orange, posterior margin inked red and anterior margin inked green. A piece of tumor was taken tumor bank, 1.0 x. 1.0 cm. Cut sections of the specimen reveal a stony hard tumor which measure approximately 2.4 x 1.5 x 1.0 cm. The. tumor is surrounded by fibrous tissue and has an ill-defined border of fibrosis. The areas of ill-defined, fibrosis measure. 5.0 x 3.0 x 3.0 cm in greatest dimension. The small area of hemorrhagic which measure 0.8 x 0.4 x 0.3 cm is located 0.8. cm away from the deep posterior margin and the margin submitted as follows. 1. Lateral margin. 2. Posterior and inferior margin. 3. Superior and anterior margin. 4. Additional sections of the anterior margin. 5. Sections of the medial margin grossly suspecious area of tumor involvement is located 0.8 cm away from. the closest margin which is posterior and inferior. 6 & 7. Additonal sections of the tumor in relation to the psoterior and inferior margin. 8&9. Additonal sections of the fibrotic area at the inferior and posterior margin. 10-12. Additonal sections of the biopsy cavity in relation to the inferior and posterior margin. 13. Sections of the tumor in relation to the superior and anterior margin. D. Received in formalin and labeled "inferior margin, true blue margin" consists of a present of breast tissue, 7.0 cm in length. by 4.0 x 1.2 cm in greatest thickness. One size of the specimen inked in methylene blue and re-inked in black. E. Received fresh and labeled "right breast tissue (fresh)" consists of a fragment of fibro-adipose tissue, 7.0 cm in depth. 5.0 x 3.0 cm. An overlying ellipse of skin measuring 3.0 x 1.0 cm in greatest dimension. The specimen weighs. approximately 55.0 grams. Specimen is unoriented. Specimen inked black. Cut sections reveal that the specimen consists. of 60.0 % cyst fibro-stroma and 40.0 adipose tissue. The tumor or suspicious areas are grossly identifiable. Sections of. the stroma and skin are submitted in three cassettes. ICD-9(s): 174.8 610.1 793.81.

expanded version (tokens=1939) : 
 The breast pathology report indicates the presence of Luminal B subtype of invasive ductal carcinoma in a 2.4 cm tumor mass in the left breast. The tumor is poorly differentiated with high nuclear grade and marked pleomorphism and has invaded the lymphovascular space. The margin of resection is clear of tumor. The tumor cells show ER and PR positivity and do not express HER2. There are microcalcifications present in both neoplastic and non-neoplastic tissue. The histological grading of the tumor is Grade III with a total Nottingham score of 8-9 points.

Additional tests were performed on the specimen using immunohistochemistry and ancillary testing for biomarkers such as ER, PR, and HER2. The specimens were fixated, and paraffin-embedded tissue detection was conducted by LSAB. The results for these testing were positive for the presence of biomarkers.

Lymph node sampling reveals no malignancy, and there is no distant metastasis detected. The report also mentions ancillary tests such as Keratin immunostain and Intraoperative Consultation touching on sentinel lymph node #1, which showed no malignant cells.

In summary, the breast pathology report confirms that the patient is suffering from Luminal B subtype of invasive ductal carcinoma with some indicators related to the extent of the disease, histological grade and receptor status.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2103) : 
 The report confirms Luminal B subtype of invasive ductal carcinoma in the left breast with a tumor size of 2.4 cm, positive ER and PR biomarkers and no HER2 expression. Lymphovascular space invasion is present, and there are microcalcifications in the neoplastic and non-neoplastic tissue. The histological grading of the tumor is Grade III, with a total Nottingham score of 8-9 points. No malignancy was found in the lymph nodes, but lymphatic invasion is present. Keratin immunostain tested negative for carcinoma.

